Billionaire CEO Elon Musk said Wednesday his company Neuralink is ready to test its first cybernetic implant on a human patient.
In a blog post, Neuralink announced that recruitment is open for the first-in-human clinical trial of its wireless brain-computer interface (BCI). The Precise Robotically Implanted Brain-Computer Interface (PRIME) study will evaluate the safety of Neuralink’s implant (N1) and surgical robot (R1) and assess whether the device can help paralyzed people control external devices with their thoughts.
“The first human patient will soon receive a Neuralink device. This ultimately has the potential to restore full body movement,” Musk posted on X, the social media platform formerly known as Twitter.
“In the long term, Neuralink hopes to play a role in AI risk civilizational risk reduction by improving human to AI (and human to human) bandwidth by several orders of magnitude,” he added. “Imagine if Stephen Hawking had had this.”